Heiyoung Park, PhD, Staff Scientist, firstname.lastname@example.org
Heiyoung Park received her Ph.D. in biochemistry from Rutgers University / UMDNJ-Robert Wood Johnson Medical School, NJ. As a postdoctoral fellow and then as an instructor at Massachusetts General Hospital, Boston, MA she studied molecular mechanisms of innate immunity and inflammation. After joining the National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH as a research fellow she studied the pathogenesis of a human autoinflammatory disease associated with heterozygous mutations in the TNF receptor 1, and the effect of Yersinia virulence factors on host immune responses. She also established a conditional knockout mouse model for a Zinc finger DNA binding protein. Dr. Park joined the Immunology Section, LDB of NIDDK as a staff scientist in 2009 and currently works on two major projects: (i) the innate immune response to hepatitis C virus, in particular the role of type III interferons, and (ii) the generation of recombinant T cell receptors for immunotherapy of chronic hepatitis B and C.
Lauren Holz, PhD, Postdoctoral Fellow, email@example.com
Lauren Holz received her PhD from the Centenary Institute, Sydney Australia investigating mechanisms of liver tolerance. She joined the Immunology Section, LDB, NIDDK in 2009 and is currently studying the host immune response to infections with hepatotropic viruses using both clinical samples from infected patients (to study B cells in patients with HCV-induced mixed cryogobulinemia) and as a mouse model, lymphocytic choriomeningitis virus infection (to study virus-induced mechanisms of immune response regulation).
Warren Pan, postbaccalaureate IRTA student, firstname.lastname@example.org
Warren Pan, a graduate of Harvard University, joined the Immunology Section in the summer of 2011 for a year of research training prior to entering either medical school or an MD/PhD program. He is characterizing HBV- and HCV-specific T cell receptors from patients and chimpanzees that have successfully cleared HBV and/or HCV infection.
Su-Hyung Park, PhD, Postdoctoral Fellow, email@example.com
Su-Hyung Park received his PhD from Pohang University of Science Technology in Seoul, Korea for studies on adaptive immune responses in response to DNA vaccination. He joined the Immunology Section, LDB, NIDDK in 2008 and is pursuing several studies on HCV and HBV interaction with host immune responses using clinical samples from infected patients and animal models of infection.
Elisavet Serti, PhD, Postdoctoral Fellow, firstname.lastname@example.org
Elisavet Serti received her PhD from the Molecular Virology Lab of the Hellenic Pasteur Institute in Athens, Greece studying the effects of the HCV structural proteins on signaling pathways. She joined the Immunology Section, LDB, NIDDK in the spring of 2011 to pursue translational studies on innate immune responses to infections with hepatotropic viruses (HBV, HCV, HDV).
Jens Werner, MD, Postdoctoral Fellow, email@example.com
Jens Werner received his MD degree from Georg August University, Göttingen, Germany where he studied apoptosis pathways in colon cancer cells. As a resident in transplantation surgery at University of Regensburg, Germany he conducted studies on innate immune responses of the liver. He joined the Immunology Section, LDB, NIDDK in the fall of 2009 with a postdoctoral fellowship from the Deutsche Forschungsgemeinschaft (DFG), Bonn, Germany. and is currently studying innate immune responses in the early phase after virus exposure and the long-term characteristics of immune memory in individuals who have either cleared a virus infection spontaneously or have been vaccinated.